US Patent 11833173 Th1 vaccination priming for active immunotherapy
Patent 11833173 was granted and assigned to Mirror Biologics, Inc. on December, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 14, 2020
0
Date of Patent
December 5, 2023
0
Patent Applicant
Patent Application Number
16928884
0
Patent Inventor Names
Michael Har-Noy
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11833173 Th1 vaccination priming for active immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
